Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| CHEMED CORPCHE · Entity 3723 | Director | May 20, 2024 | May 21, 2024 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
CHEMED CORP
Report date May 20, 2024 · Filed May 21, 2024
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Capital StockSEC Table I · non-derivative | Direct | 6,028 |
Reported balance
After 2024-05-20 transaction · row 1
1 source rowRow 1 · 2024-05-20 · Grant · Acquired 284 · Balance 6,028 F1: Award of stock |
Filing footnotes · ownership attribution and instrument terms
F1: Award of stock
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| May 20, 2024 Filed May 21, 2024 16:37 UTC | CHEMED CORP CHE · Entity 3723 | GrantCapital Stock | 284 | $564.34 | $160,272.56 |
DisclosureSEC source: 0000950170-24-062731 · ownership.xml · nonDerivative · entry 1 RICE THOMAS P · CIK 0001230728 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 6,028 F1 · kind: Award of stock Read SEC document |
| May 15, 2023 Filed May 16, 2023 17:15 UTC | CHEMED CORP CHE · Entity 3723 | Grantcapital stock | 294 | $545.69 | $160,432.86 |
DisclosureSEC source: 0001209191-23-029724 · doc4.xml · nonDerivative · entry 1 RICE THOMAS P · CIK 0001230728 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,744 F1 · kind: Award of stock Read SEC document |
| May 16, 2022 Filed May 17, 2022 18:20 UTC | CHEMED CORP CHE · Entity 3723 | Grantcapital stock | 262 | $496.25 | $130,017.50 |
DisclosureSEC source: 0001209191-22-029534 · doc4.xml · nonDerivative · entry 1 RICE THOMAS P · CIK 0001230728 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,450 F1 · kind: Award of stock Read SEC document |
| June 17, 2021 Filed Jun 21, 2021 14:44 UTC | CHEMED CORP CHE · Entity 3723 | Salecapital stock | 841 | $462.47 | $388,937.27 |
DisclosureSEC source: 0001209191-21-041845 · doc4.xml · nonDerivative · entry 1 RICE THOMAS P · CIK 0001230728 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,188 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $462.33 to $465.59. The reporting person undertakes to provide to Chemed Corporation, any security holder of Chemed Corporation, or staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (1) to this Form 4. Read SEC document |
| May 17, 2021 Filed May 18, 2021 16:28 UTC | CHEMED CORP CHE · Entity 3723 | Grantcapital stock | 270 | $482.66 | $130,318.20 |
DisclosureSEC source: 0001209191-21-033412 · doc4.xml · nonDerivative · entry 1 RICE THOMAS P · CIK 0001230728 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,029 F1 · kind: Award of stock Read SEC document |
| May 18, 2020 Filed May 19, 2020 16:27 UTC | CHEMED CORP CHE · Entity 3723 | Grantcapital stock | 279 | $466.43 | $130,133.97 |
DisclosureSEC source: 0001209191-20-030346 · doc4.xml · nonDerivative · entry 1 RICE THOMAS P · CIK 0001230728 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,759 F1 · kind: Award of stock Read SEC document |
| May 20, 2019 Filed May 22, 2019 15:55 UTC | CHEMED CORP CHE · Entity 3723 | Grantcapital stock | 257 | $331.69 | $85,244.33 |
DisclosureSEC source: 0001209191-19-031941 · doc4.xml · nonDerivative · entry 1 RICE THOMAS P · CIK 0001230728 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,480 F1 · kind: Award of stock Read SEC document |
| February 27, 2019 Filed Feb 27, 2019 16:19 UTC | CHEMED CORP CHE · Entity 3723 | Salecapital stock | 359 | $328.26 | $117,845.34 |
DisclosureSEC source: 0001209191-19-013957 · doc4.xml · nonDerivative · entry 2 RICE THOMAS P · CIK 0001230728 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,223 Read SEC document |
| February 27, 2019 Filed Feb 27, 2019 16:19 UTC | CHEMED CORP CHE · Entity 3723 | Salecapital stock | 1,641 | $327.54 | $537,493.14 |
DisclosureSEC source: 0001209191-19-013957 · doc4.xml · nonDerivative · entry 1 RICE THOMAS P · CIK 0001230728 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,582 Read SEC document |
| May 21, 2018 Filed May 23, 2018 18:00 UTC | CHEMED CORP CHE · Entity 3723 | Grantcapital stock | 255 | $333.75 | $85,106.25 |
DisclosureSEC source: 0001209191-18-032525 · doc4.xml · nonDerivative · entry 1 RICE THOMAS P · CIK 0001230728 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,223 F1 · kind: Award of stock Read SEC document |
| May 15, 2017 Filed May 16, 2017 19:16 UTC | CHEMED CORP CHE · Entity 3723 | Grantcapital stock | 418 | $203.52 | $85,071.36 |
DisclosureSEC source: 0001209191-17-032593 · doc4.xml · nonDerivative · entry 1 RICE THOMAS P · CIK 0001230728 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,968 F1 · kind: Award of stock Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.